Large-cap Health Care company AstraZeneca PLC has logged a 2.9% change today on a trading volume of 4,355,415. The average volume for the stock is 4,617,964.
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. Based in Cambridge, United Kingdom the company has 94,300 full time employees and a market cap of $269,778,403,328. AstraZeneca PLC currently offers its equity investors a dividend that yields 3.7% per year.
The company is now trading -6.78% away from its average analyst target price of $93.33 per share. The 11 analysts following the stock have set target prices ranging from $81.0 to $103.0, and on average give AstraZeneca PLC a rating of buy.
Over the last 52 weeks, AZN stock has risen 30.5%, which amounts to a 18.4% difference compared to the S&P 500. The stock's 52 week high is $87.05 whereas its 52 week low is $61.24 per share. Based on AstraZeneca PLC's average net margin growth of 17.3% over the last 6 years, its core business is on track for profitability and its strong stock performance may continue in the long term.
| Date Reported | Total Revenue ($ k) | Net Profit ($ k) | Net Margins (%) | YoY Growth (%) |
|---|---|---|---|---|
| 2024 | 54,073,000 | 7,041,000 | 13 | 0.0 |
| 2023 | 45,811,000 | 5,961,000 | 13 | 85.71 |
| 2022 | 44,351,000 | 3,293,000 | 7 | inf |
| 2021 | 37,417,000 | 115,000 | 0 | -100.0 |
| 2020 | 26,617,000 | 3,144,000 | 12 | 140.0 |
| 2019 | 24,384,000 | 1,227,000 | 5 |
